Internal Medicine, Infectious Disease · Frisco, TX
NPI
1205918851
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
5350 Independence Pkwy Ste 120
Frisco, TX, 75035
Phone (214) 396-8877
Groups this clinician bills Medicare through
Medicare paid, 2024
$217K
2,994 services
Medicare patients, 2024
622
Average age 77
Drug cost, 2024
$400K
614 prescriptions
Company payments, 2025
$26.51
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dhiraj K Kotwal was code 99232 (hospital e&m - subsequent), 1,723 times for 466 patients. In total Dhiraj K Kotwal billed 2,994 services in 10 codes, and Medicare paid $217K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-09-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,723 | 466 | $53.94 | $93K |
| 99233 Hospital E&M - Subsequent | Facility | 591 | 316 | $81.78 | $48K |
| 99223 Hospital E&M - Initial | Facility | 468 | 392 | $117.46 | $55K |
| 99222 Hospital E&M - Initial | Facility | 116 | 97 | $89.30 | $10K |
| 99215 Office E&M - Established | Office | 78 | 43 | $121.79 | $9,499 |
By year: 2022 $311K for 4,263 services; 2023 $238K for 3,246 services; 2024 $217K for 2,994 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dhiraj K Kotwal prescribed most often to Medicare patients was Daptomycin, with 64 prescriptions and refills. In total Dhiraj K Kotwal wrote 614 Medicare prescriptions that cost $400K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Daptomycin Generic | 64 | 64 | 15 | $29K |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 55 | 55 | 15 | $13K |
| Meropenem Generic | 49 | 49 | Under 11 | $9,085 |
| Juluca Dolutegravir/Rilpivirine | 29 | 29 | Under 11 | $100K |
| Ceftriaxone Ceftriaxone Sodium | 28 | 28 | Under 11 | $975 |
| Cefepime Hcl Generic | 25 | 25 | Under 11 | $2,048 |
| Cefdinir Generic | 25 | 25 | 13 | $306 |
| Cefepime Cefepime In Iso-Osm Dextrose | 23 | 23 | Under 11 | $9,756 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 23 | 26 | Under 11 | $283 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 21 | 21 | Under 11 | $84K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 21 | 23 | Under 11 | $79.97 |
| Doxycycline Hyclate Generic | 17 | 17 | Under 11 | $275 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 16 | 16 | Under 11 | $63K |
| Ertapenem Ertapenem Sodium | 16 | 16 | Under 11 | $4,057 |
| Vancomycin Hcl Generic | 14 | 14 | Under 11 | $1,374 |
Brand drugs: 133 claims; generic drugs: 481 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dhiraj K Kotwal $26.51 ($26.51 in general payments such as food, travel and fees) from 1 company. The largest payer was ViiV Healthcare Company with $26.51.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 1 | $26.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.